Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ARGAN INC (AGX)

  • Business News
  • June 10, 2026, 20:10 UTC
  • 2
  • 1 comments

Argan, Inc. Declares Regular Quarterly Cash Dividend of $0.50 Per Common Share

Market reaction Comment Full text

ARTIVION, INC. (AORT)

  • Business News
  • June 10, 2026, 20:10 UTC
  • 2
  • 1 comments

Artivion to Participate in the 2026 Truist Securities MedTech Conference

Market reaction Comment Full text

Ideaya Biosciences Inc (IDYA)

  • Business News
  • June 10, 2026, 20:07 UTC
  • 2
  • 1 comments

IDEAYA Announces Closing of Public Offering Including Full Exercise of Underwriters Option to Purchase Additional Shares

Market reaction Comment Full text

RadNet Inc (RDNT)

  • Business News
  • June 10, 2026, 20:05 UTC
  • 6
  • 1 comments

RadNet Secures $250 Million Incremental Term Loan to Fund Strategic Growth Opportunities and Reduces the Interest Rates on its Credit Facility by 0.25%

Market reaction Comment Full text

Vir Biotechnology (VIR)

  • Business News
  • June 10, 2026, 20:05 UTC
  • 5
  • 1 comments

Vir Biotechnology - Vir Biotechnology Announces Appointment of Timothy Coughlin to its Board of Directors

Market reaction Comment Full text

ALLIANCEBERNSTEIN HOLDING L.P. (AB)

  • Business News
  • June 10, 2026, 20:05 UTC
  • 4
  • 1 comments

AB Announces May 31, 2026 Assets Under Management

Market reaction Comment Full text

VIR BIOTECHNOLOGY, INC. (VIR)

  • Business News
  • June 10, 2026, 20:05 UTC
  • 4
  • 1 comments

Vir Biotechnology Announces Appointment of Timothy Coughlin to its Board of Directors

Market reaction Comment Full text

CATERPILLAR INC (CAT)

  • Business News
  • June 10, 2026, 20:05 UTC
  • 1
  • 1 comments

Caterpillar Inc. Increases Dividend

Market reaction Comment Full text

ORACLE CORP (ORCL)

  • Business News
  • June 10, 2026, 20:05 UTC
  • 1
  • 1 comments

Oracle Announces Record Q4 and FY 2026 Results Driven by Cloud Infrastructure & Cloud Applications

Market reaction Comment Full text

IDEAYA BIOSCIENCES, INC. (IDYA)

  • Business News
  • June 10, 2026, 20:05 UTC
  • 1
  • 1 comments

IDEAYA Announces Closing of Public Offering Including Full Exercise of Underwriters Option to Purchase Additional Shares

Market reaction Comment Full text
  • Previous
  • 305
  • 306
  • 307
  • 308
  • 309
  • Next

Search

News categories

  • Technical Exchange News(13201)
  • Event(6229)
  • SEC News(332741)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(185278)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin